Quantbot Technologies’s Stoke Therapeutics STOK Stock Holding History

Quantbot Technologies’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.2K	Buy	+1,044	New	+$33.5K	﹤0.01%	1707
2026 Q1	–	Sell	-88	Closed	-$2.79K	–	2141
2025 Q4	$2.79K	Buy	+88	New	+$2.65K	﹤0.01%	1634
2023 Q1	–	Sell	-3,291	Closed	-$30.4K	–	2038
2022 Q4	$30.4K	Buy	+3,291	New	+$34.2K	﹤0.01%	1386
2022 Q2	–	Sell	-4,300	Closed	-$90K	–	2113
2022 Q1	$90K	Buy	4,300 +2,900	+207%	+$58.1K	0.01%	1071
2021 Q4	$33K	Buy	1,400 +200	+17%	+$4.77K	﹤0.01%	1137
2021 Q3	$30K	Buy	1,200 +1,000	+500%	+$27.9K	﹤0.01%	1201
2021 Q2	$6K	Hold	200	–	–	﹤0.01%	1349
2021 Q1	$7K	Hold	200	–	–	﹤0.01%	1278
2020 Q4	$12K	Hold	200	–	–	﹤0.01%	1084
2020 Q3	$6K	Buy	+200	New	+$5.71K	﹤0.01%	1171

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's STOK Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 1,044 shares worth $34.2K. The stake represents ﹤0.01% of the portfolio and ranks #1707 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in STOK as recently as Q4 2025.

Quantbot Technologies first reported a position in STOK in Q3 2020 and has held it in 10 quarters since. The position peaked at $90K in Q1 2022. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Quantbot Technologies held 1,044 shares of Stoke Therapeutics worth $34.2K as of Q2 2026.
Stoke Therapeutics was a new Quantbot Technologies position in Q2 2026.
Stoke Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1707 holding.
Quantbot Technologies first reported a position in Stoke Therapeutics in Q3 2020 and has held it in 10 quarters since.
Quantbot Technologies's Stoke Therapeutics position peaked at $90K in Q1 2022.
198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.